Literature DB >> 27484206

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study-Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7.

Tobias Nordström1,2, Martin Eklund3, Henrik Grönberg3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27484206     DOI： 10.1007/s00345-016-1907-2

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  6 in total

1.  Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.

Authors:  H Gilbert Welch; David H Gorski; Peter C Albertsen
Journal:  N Engl J Med       Date:  2015-10-29       Impact factor: 91.245

2.  National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.

Authors:  Michael W Drazer; Dezheng Huo; Scott E Eggener
Journal:  J Clin Oncol       Date:  2015-06-08       Impact factor: 44.544

3.  Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.

Authors:  Rebecka Arnsrud Godtman; Erik Holmberg; Hans Lilja; Johan Stranne; Jonas Hugosson
Journal:  Eur Urol       Date:  2014-12-31       Impact factor: 20.096

4.  Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.

Authors:  Jennifer R Rider; Fredrik Sandin; Ove Andrén; Peter Wiklund; Jonas Hugosson; Pär Stattin
Journal:  Eur Urol       Date:  2012-08-10       Impact factor: 20.096

5.  Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.

Authors:  Henrik Grönberg; Jan Adolfsson; Markus Aly; Tobias Nordström; Peter Wiklund; Yvonne Brandberg; James Thompson; Fredrik Wiklund; Johan Lindberg; Mark Clements; Lars Egevad; Martin Eklund
Journal:  Lancet Oncol       Date:  2015-11-10       Impact factor: 41.316

6.  Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011.

Authors:  Tobias Nordström; Markus Aly; Mark S Clements; Caroline E Weibull; Jan Adolfsson; Henrik Grönberg
Journal:  Eur Urol       Date:  2012-10-12       Impact factor: 20.096
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.